United States Cerebrospinal Fluid Management Market Report 2017 with Neuromodulation, Neurovascular, Neurosurgical And Monitoring Device Market Overview - Research and Markets

DUBLIN, Nov 30, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "US Market Report for Cerebrospinal Fluid Management 2017 - MedCore" report to their offering.

For several years now there has been a shift from using fixed pressure shunts to pressure adjustable shunts. These shunts tend to have a lower revision rate and experience fewer complications, such as overdrainage, which makes them more popular among neurosurgeons and patients. However, fixed pressure shunts are still preferred by some neurosurgeons when treating pediatric patients. The fixed pressure devices are smaller and easier to use in these cases. The majority of shunts sold are pressure adjustable even though the ASP is also considerably higher for these devices.

The move towards pressure adjustable shunts will continue over the forecast period as they cannibalize market share from fixed pressure shunts, increasing the market value. The ASP will continue to increase for pressure adjustable shunts as end-users switch to premium-priced products that have additional features such as antimicrobial coating. The ASP will remain relatively stable for fixed pressure shunts, with a slight appreciation due to the incorporation of new features.

Key Topics Covered:

1. Executive Summary

U.S. Neuromodulation, Neurovascular, Neurosurgical And Monitoring Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

2. Disease Overview

2.1 Basic Anatomy
2.2 Disease Pathology And Disorders
2.2.1 Introduction
2.2.2 General Diagnostics And Neurosurgery
2.2.3 Tumor And Brain Cancer
2.2.4 Brain Arteriovenous Malformations
2.2.5 Ischemic Stroke
2.2.6 Brain Aneurysm
2.2.7 Disorders Related To Cerebrospinal Fluids And Intracranial Pressure
2.2.8 Indication For Neuromodulation
2.2.9 Traumatic Brain Injury

3. Product Assessment

3.1 Product Portfolios
3.1.1 Cerebrospinal Fluid Management
3.2 Regulatory Issues And Recalls
3.2.1 Cerebrospinal Fluid Management
3.3 Clinical Trials
3.3.1 Cerebrospinal Fluid Management

4. Cerebrospinal Fluid Management Market

4.1 Introduction
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Cerebrospinal Fluid Management Market
4.3.2 Total Cerebrospinal Fluid Shunt Market
4.3.3 Total Cerebrospinal Fluid External Drainage System Market
4.4 Drivers And Limiters
4.5 Competitive Market Share Analysis

Companies Mentioned

• Medtronic
• Boston Scientific
• St. Jude Medical
• Cyberonics
• Codman & Shurtleff
• Stryker
• Integra LifeSciences
• InoMed
• Mizuho America
• RauMedic
  

For more information about this report visit http://www.researchandmarkets.com/research/brs65v/us_market_report

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets